No Prescription |
 |
 | ||
|
LEVOLIN LEVOLIN |
|
| ||
No Prescription » Prescription Drugs 10 » LEVOLIN LEVOLIN Levalbuterol is used to treat wheezing and shortness of breath that commonly occur with lung problems (e.g. asthma chronic obstructive pulmonary disease). Controlling these symptoms can decrease time lost from work or school. Levalbuterol is a bronchodilator (beta-2 receptor agonist) that works by opening breathing passages to make breathing easier.How to use LevalbuterolRead the Patient Information Leaflet for instructions on proper use of this medication and the proper cleaning of the mouthpiece. Consult your doctor or pharmacist if you have any questions.Shake the canister well before each inhalation and test spray. Follow the instructions for test sprays in the air if you are using a new canister or if you have not used it for 3 days or more. Avoid spraying the medication in your eyes. A fine mist is a sign that the inhaler is properly working.Take the cap off the mouthpiece. Place the mouthpiece near your mouth and exhale. Place the mouthpiece fully into your mouth and press the inhaler as you breathe in deeply. Hold your breath for 10 seconds if possible to allow the drug to be absorbed. If more than one inhalation is prescribed wait at least one full minute between inhalations. If you take other asthma drugs by mouth or with inhaling devices ask your doctor about how to correctly take this medication with your other asthma medicines.Take this medication exactly as prescribed. Inhale by mouth usually every 4 to 6 hours or as directed by your doctor. Dosage is based on your medical condition and response to therapy. Do not take more of this medication or take it more often than recommended by your doctor. Use this medication regularly in order to get the most benefit from it. Remember to use it at the same times each day.If you find it difficult to correctly use this inhaler it may help to use a spacer device with this inhaler. Ask your doctor or pharmacist for more information.If you notice less effect than usual from this medication if your symptoms get worse or you feel you need to take any of your asthma medications more often than recommended seek immediate medical attention.Keep track of the number of inhalations used from each canister. Discard the canister after you have used the number of inhalations marked on the manufacturer's package. Sprays used to prime the inhaler should also be counted. Do not float the metal canister in water to test if any more drug is left in the canister. Buy LEVOLIN LEVOLIN and other Prescription Drugs 10 products online at Medstore. Buy Online at Medstore - Click Here!
About LEVOLIN LEVOLIN: Product Type: Prescription Drugs 10 LEVOLIN ( LEVOLIN GENERIC LEVOSALBUTAMOL ) LEVOLIN (LEVOLIN GENERIC LEVOSALBUTAMOL) LEVOLIN GENERIC LEVOSALBUTAMOL 50MCG LEVOLIN GENERIC LEVOSALBUTAMOL LEVOLIN
View more Prescription Drugs 10 No Prescription: NEW YORK, Oct. 5, 2011 /PRNewswire via COMTEX/ -- Reportlinker.com announces that a new market research report is available in its catalogue: European Pharmaceutical Market: Strategic Assessments of Leading Suppliers http://www.reportlinker.com/p0651431/European-Pharmaceutical-Market-Strategic-Assessments-of-Leading-Suppliers.html #utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_and_Medication This report provides industry executives with strategically significant competitor information and analysis of the leading players in the European pharmaceutical market. The report provides a worldwide strategic overview of the pharmaceutical market, including: Sales forecast for major product segments: ethical, OTC, generics. Sales forecast for major drug categories: cardiovascular, gastrointestinal, antibiotic, CNS, respiratory, musculoskeletal, hormonal/genitourinary, dermatological, oncological, ophthalmic, and others. In addition, the report reviews major regulatory, technological, economic, demographic, and social trends with potentially significant impact on the market during the next five years, including discussion of such key issues as pricing, industry consolidation, market globalization, growing R&D cost, generics, as well as advances in genomics, proteomics, drug screening, tissue engineering, bioinformatics, and other technologies. The companies analyzed in this report include Abbott, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Johnson & Johnson, Merck, Novartis, Pfizer, Roche, Sanofi-Aventis and Wyeth.
| ||
